Thomas Prescott Atkinson, n/a

MD
UAB Division of Pediatric Allergy & Immunology

Abstracts(s):

• PC2178: Long-term Efficacy, Safety, and Tolerability of a Subcutaneous Immunoglobulin 16.5% (cutaquig®) in the Treatment of Adult and Pediatric Patients with Primary Immunodeficiencies
  Sunday, October 9, 2022

  5:00 PM – 6:00 PM US PDT